Bio-Techne Q3 FY25: where the revenue came from and where it went
The whole income statement of Bio-Techne for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2025
- Reported
- May 8, 2025
Revenue$0.32B
+4% year over year
Gross profit$0.22B
68% margin
Operating profit$0.04B
12% margin
Net profit$0.02B
7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.32 | 100% | +4% |
| Consumables | 0.26 | 82% | +4% |
| Services | 0.03 | 8% | +7% |
| Instruments | 0.03 | 8% | −1% |
| Royalty | 0.01 | 2% | +7% |
| Cost of revenue | −0.10 | 32% | |
| Gross profit | 0.22 | 68% margin | +0pp |
| SG&A | −0.15 | 48% | +11pp |
| Other | −0.03 | 8% | +0pp |
| Operating profit | 0.04 | 12% margin | −10pp |
| Tax | −0.02 | ||
| Net profit | 0.02 | 7% margin | −9pp |
39 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest